Literature DB >> 10963672

Normal cardiovascular development in mice deficient for 16 genes in 550 kb of the velocardiofacial/DiGeorge syndrome region.

A Puech1, B Saint-Jore, S Merscher, R G Russell, D Cherif, H Sirotkin, H Xu, S Factor, R Kucherlapati, A I Skoultchi.   

Abstract

Hemizygous interstitial deletions in human chromosome 22q11 are associated with velocardiofacial syndrome and DiGeorge syndrome and lead to multiple congenital abnormalities, including cardiovascular defects. The gene(s) responsible for these disorders is thought to reside in a 1.5-Mb region of 22q11 in which 27 genes have been identified. We have used Cre-mediated recombination of LoxP sites in embryonic stem cells and mice to generate a 550-kb deletion encompassing 16 of these genes in the corresponding region on mouse chromosome 16. Mice heterozygous for this deletion are normal and do not exhibit cardiovascular abnormalities. Because mice with a larger deletion on mouse chromosome 16 do have heart defects, the results allow us to exclude these 16 genes as being solely, or in combination among themselves, responsible for the cardiovascular abnormalities in velocardiofacial/DiGeorge syndrome. We also generated mice with a duplication of the 16 genes that may help dissect the genetic basis of "cat eye" and derivative 22 syndromes that are characterized by extra copies of portions of 22q11, including these 16 genes. We also describe a strategy for selecting cell lines with defined chromosomal rearrangements. The method is based on reconstitution of a dominant selection marker after Cre-mediated recombination of LoxP sites. Therefore it should be widely applicable to many cell lines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963672      PMCID: PMC27709          DOI: 10.1073/pnas.97.18.10090

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  The DNA sequence of human chromosome 22.

Authors:  I Dunham; N Shimizu; B A Roe; S Chissoe; A R Hunt; J E Collins; R Bruskiewich; D M Beare; M Clamp; L J Smink; R Ainscough; J P Almeida; A Babbage; C Bagguley; J Bailey; K Barlow; K N Bates; O Beasley; C P Bird; S Blakey; A M Bridgeman; D Buck; J Burgess; W D Burrill; K P O'Brien
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

2.  Engineering mouse chromosomes with Cre-loxP: range, efficiency, and somatic applications.

Authors:  B Zheng; M Sage; E A Sheppeard; V Jurecic; A Bradley
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Comparative sequence analysis of 634 kb of the mouse chromosome 16 region of conserved synteny with the human velocardiofacial syndrome region on chromosome 22q11.2.

Authors:  J Lund; F Chen; A Hua; B Roe; M Budarf; B S Emanuel; R H Reeves
Journal:  Genomics       Date:  2000-02-01       Impact factor: 5.736

4.  Deletion of 150 kb in the minimal DiGeorge/velocardiofacial syndrome critical region in mouse.

Authors:  W L Kimber; P Hsieh; S Hirotsune; L Yuva-Paylor; H F Sutherland; A Chen; P Ruiz-Lozano; S L Hoogstraten-Miller; K R Chien; R Paylor; P J Scambler; A Wynshaw-Boris
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

5.  A common breakpoint on 11q23 in carriers of the constitutional t(11;22) translocation.

Authors:  L Edelmann; E Spiteri; N McCain; R Goldberg; R K Pandita; S Duong; J Fox; D Blumenthal; S R Lalani; L G Shaffer; B E Morrow
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

6.  Congenital heart disease in mice deficient for the DiGeorge syndrome region.

Authors:  E A Lindsay; A Botta; V Jurecic; S Carattini-Rivera; Y C Cheah; H M Rosenblatt; A Bradley; A Baldini
Journal:  Nature       Date:  1999-09-23       Impact factor: 49.962

7.  A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome.

Authors:  R J Shprintzen; R B Goldberg; M L Lewin; E J Sidoti; M D Berkman; R V Argamaso; D Young
Journal:  Cleft Palate J       Date:  1978-01

8.  Mesenchymal derivatives of the neural crest: analysis of chimaeric quail and chick embryos.

Authors:  C S Le Lièvre; N M Le Douarin
Journal:  J Embryol Exp Morphol       Date:  1975-08

9.  The "cat eye syndrome": dicentric small marker chromosome probably derived from a no.22 (tetrasomy 22pter to q11) associated with a characteristic phenotype. Report of 11 patients and delineation of the clinical picture.

Authors:  A Schinzel; W Schmid; M Fraccaro; L Tiepolo; O Zuffardi; J M Opitz; J Lindsten; P Zetterqvist; H Enell; C Baccichetti; R Tenconi; R A Pagon
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

10.  Atypical deletions suggest five 22q11.2 critical regions related to the DiGeorge/velo-cardio-facial syndrome.

Authors:  F Amati; E Conti; A Novelli; M Bengala; M C Diglio; B Marino; A Giannotti; O Gabrielli; G Novelli; B Dallapiccola
Journal:  Eur J Hum Genet       Date:  1999-12       Impact factor: 4.246

View more
  17 in total

Review 1.  Building a heart: implications for congenital heart disease.

Authors:  Deepak Srivastava
Journal:  J Nucl Cardiol       Date:  2003 Jan-Feb       Impact factor: 5.952

Review 2.  The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders.

Authors:  Liam J Drew; Gregg W Crabtree; Sander Markx; Kimberly L Stark; Florence Chaverneff; Bin Xu; Jun Mukai; Karine Fenelon; Pei-Ken Hsu; Joseph A Gogos; Maria Karayiorgou
Journal:  Int J Dev Neurosci       Date:  2010-10-08       Impact factor: 2.457

3.  Inducing segmental aneuploid mosaicism in the mouse through targeted asymmetric sister chromatid event of recombination.

Authors:  Arnaud Duchon; Vanessa Besson; Patricia Lopes Pereira; Laetitia Magnol; Yann Hérault
Journal:  Genetics       Date:  2008-08-30       Impact factor: 4.562

4.  Requirement of CDC45 for postimplantation mouse development.

Authors:  K Yoshida; F Kuo; E L George; A H Sharpe; A Dutta
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Long-range chromosomal engineering is more efficient in vitro than in vivo.

Authors:  Lisa E Olson; Jason Tien; Sarah South; Roger H Reeves
Journal:  Transgenic Res       Date:  2005-06       Impact factor: 2.788

Review 6.  Mouse chromosome engineering for modeling human disease.

Authors:  Louise van der Weyden; Allan Bradley
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

Review 7.  A Synaptic Function Approach to Investigating Complex Psychiatric Diseases.

Authors:  Laurie R Earls; Stanislav S Zakharenko
Journal:  Neuroscientist       Date:  2013-08-01       Impact factor: 7.519

Review 8.  Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders.

Authors:  Holly R Robertson; Guoping Feng
Journal:  J Child Psychol Psychiatry       Date:  2011-02-10       Impact factor: 8.982

9.  Targeted deletion of Tssk1 and 2 causes male infertility due to haploinsufficiency.

Authors:  Bingfang Xu; Zhonglin Hao; Kula N Jha; Zhibing Zhang; Craig Urekar; Laura Digilio; Silvia Pulido; Jerome F Strauss; Charles J Flickinger; John C Herr
Journal:  Dev Biol       Date:  2008-04-23       Impact factor: 3.582

10.  Decreased embryonic retinoic acid synthesis results in a DiGeorge syndrome phenotype in newborn mice.

Authors:  Julien Vermot; Karen Niederreither; Jean-Marie Garnier; Pierre Chambon; Pascal Dollé
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.